Infographic: Human Endogenous Retroviruses and Disease
Infographic: Human Endogenous Retroviruses and Disease
Human endogenous retroviruses that colonized vertebrate DNA millions of years ago have long been dismissed as junk DNA, but researchers now know that they may play important roles in cancer, neurodegeneration, and other ailments.
Infographic: Human Endogenous Retroviruses and Disease
Infographic: Human Endogenous Retroviruses and Disease

Human endogenous retroviruses that colonized vertebrate DNA millions of years ago have long been dismissed as junk DNA, but researchers now know that they may play important roles in cancer, neurodegeneration, and other ailments.

Human endogenous retroviruses that colonized vertebrate DNA millions of years ago have long been dismissed as junk DNA, but researchers now know that they may play important roles in cancer, neurodegeneration, and other ailments.

ALS
Neuroscientist Rahul Desikan Dies
Neuroscientist Rahul Desikan Dies
Kerry Grens | Jul 19, 2019
He developed an MRI-based map of the human cortex, discovered genetic risk factors for neurodegenerative diseases, and wrote about his struggles with ALS.
Can Viruses in the Genome Cause Disease?
Can Viruses in the Genome Cause Disease?
Katarina Zimmer | Jan 1, 2019
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
Those We Lost in 2018
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018
The scientific community said goodbye to a number of leading researchers this year.
CRISPR Corrects RNA-based Disease Defects
CRISPR Corrects RNA-based Disease Defects
Kerry Grens | Aug 10, 2017
In human cells, researchers deploy the genome editor to snip out toxic repetitive sequences.
Additional #IceBucketChallenge Payoffs
Additional #IceBucketChallenge Payoffs
Jef Akst | Jul 28, 2016
Researchers identify a new ALS-associated gene thanks to funds generated by the social media challenge that went viral in summer 2014.
Book Review: <em>Personal Trials</em>
Book Review: Personal Trials
Arthur L. Caplan | Mar 22, 2016
At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.
Undertaker's Bane
Undertaker's Bane
The Scientist Staff | Oct 1, 2015
Harvard Professor Marc Weisskopf discusses the potential link between formaldehyde and ALS.
Formaldehyde Fears
Formaldehyde Fears
Jef Akst | Oct 1, 2015
Data on the links between ALS and the chemical have been contradictory, but the latest study suggests undertakers are at risk.
ALS Drug Access Debated
ALS Drug Access Debated
Jef Akst | Apr 7, 2015
Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.